Janux Therapeutics
JANX
#7049
Rank
A$0.93 B
Marketcap
A$15.23
Share price
-2.04%
Change (1 day)
-65.85%
Change (1 year)

Earnings for Janux Therapeutics (JANX)

Earnings in 2026 (TTM): -A$0.16 Billion

According to Janux Therapeutics's latest financial reports the company's current earnings are A$24 Million. In 2025 the company made an earning of -A$0.18 Billion a decrease over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Janux Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.16 Billion-11.77%
2025 -A$0.18 Billion64.69%
2024 -A$0.11 Billion18.36%
2023 -A$88.07 Million-7.56%
2022 -A$95.27 Million93.01%
2021 -A$49.37 Million381.6%
2020 -A$10.25 Million